Diaverum provides life enhancing renal care to patients with Chronic Kidney Disease (CKD), enabling them to live fulfilling lives. Diaverum is a leading global provider in renal care services and the largest independent provider in Europe, and we help some 38,000 patients with 6 million treatments annually. Our focus is haemodialysis, but we offer a portfolio of treatments ranging from preventive care, peritoneal dialysis and home care to coordination of patients’ comorbidities and transplantation services.
CKD is a global and escalating challenge today affecting about 10% of the world’s adult population. It’s primarily caused by lifestyle diseases such as diabetes, and the prevalence is increasing in particular in developing countries. CKD disproportionately affects low income individuals and we ensure that our clinics are a safe and familiar space where all our patients are made to feel welcome.
Diaverum’s vision is to transform renal care, to offer the highest quality of care and empower patients to live a fulfilling life. We work together with payers to reduce total cost of care while partnering with local communities to educate around health and the value of prevention.
At the centre of what we do is our standardised, proprietary care delivery model, enabled by a continuously evolving digital infrastructure. We strive to ensure superior medical outcomes exceeding those demanded by national healthcare systems and we support patients by improving personalized care, ease of use and new services through technology.
Diaverum employs more than 11,000 employees and operates 396 clinics in 22 countries globally*. Diaverum has its head office in Malmö, Sweden.